Delhaize Group press release - Capital structure disclosure
Dec 23, 2015 07:04 am UTC| Business
BRUSSELS, Belgium, Dec. 23, 2015 (GLOBE NEWSWIRE) -- Delhaize Group discloses the information required under article 15, 1 and 18, 1 of the Belgian Law of May 2, 2007 regarding the disclosure of major shareholdings in...
GTT confirms its targets for 2015 and 2016
Dec 23, 2015 06:53 am UTC| Business
PARIS, Dec. 23, 2015 (GLOBE NEWSWIRE) -- GTT (Gaztransport Technigaz), the world leader in design and engineering of containment systems for maritime transportation and storage of LNG (Liquefied Natural Gas), confirms its...
Dec 23, 2015 06:18 am UTC| Business
The regulatory submission is an important step towards potentially making LixiLan available as a new treatment option for adult Type 2 diabetes patients in the US Sanofi has redeemed a Priority Review Voucher for...

Growing revenue: how does the Christmas tree business stack up?
Dec 23, 2015 03:50 am UTC| Business
At this time of year it is worth reflecting on the huge influence that Christmas can have on production and consumption patterns. Christians may worry that their sacred celebration has been appropriated for commercial...
Fitch: India, SE Asia Airlines to See Improved Earnings Outlook
Dec 23, 2015 01:52 am UTC| Research & Analysis Business
The earnings outlook for Indian and south-east Asian airline sectors should improve in 2016, driven by higher demand, lower fuel costs and ongoing industry restructuring, Fitch Ratings says. But the operating environment...
Applications Now Being Accepted for 14th Annual Northrop Grumman Engineering Scholars Program
Dec 22, 2015 22:01 pm UTC| Business
LINTHICUM, Md., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Applications are now being accepted for the 14th annual Northrop Grumman Corporation (NYSE:NOC) Engineering Scholars competition, which will provide $240,000 in college...
TiGenix files Registration Statement for proposed initial public offering in the United States
Dec 22, 2015 21:41 pm UTC| Business
Leuven, BELGIUM, Dec. 22, 2015 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG; the "Company"), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary...